Durable Flame Resistant Antimicrobial Finishes for Textiles That Minimize Development of Drug-resistance
In medical and senior care settings and public spaces, textiles should be flame-resistant. Working under an NIAID NIH grant award we have invented a flame-resistant finish with antimicrobial properties that minimizes development of bacterial and fungal resistance and cross-adaptation. In settings where immunocompromised patients are located using a flame-resistant antimicrobial finish may reduce the risk of infection. Pillow cases, sheets, privacy drapes, wall coverings, furniture coverings can be treated with this advanced durable finish. The market is currently not offering a finish with both properties. The finish itself is proven to inhibit development of bacterial and fungal resistance which may contribute to slowing the advance of drug-resistance pathogens. We are seeking a chemical manufacturing partner to coplete regulatory registration and take these amazing finishes to market. Patents are pending.
About Chitozan Health LLC
Chitozan Health LLC is a biotechnology research firm that develops antimicrobial solutions utilizing patented silver-chitosan technology [1][3][5]. Their core innovation, marketed as Silver Shell or Glucosil, incorporates chitosan and silver particles to create durable, effective antimicrobial barriers for various applications [1][5][8]. By leveraging the biostatic properties of chitosan, the company produces textile finishes and topical gels that are designed to combat pathogens, including bacteria, fungi, and viruses, while minimizing the use of silver and maintaining safety standards [1][5][8]. This research is supported by NIH NIAID funding and focuses on managing infections, such as those related to Pseudomonas aeruginosa in cystic fibrosis, as well as providing broad-spectrum protection in healthcare and consumer settings [1][5][7].
These products serve a range of stakeholders, from industrial partners in textile manufacturing and sustainable packaging to healthcare providers and individual consumers in need of advanced wound and burn care [1][4][7][8]. The company's technology addresses critical challenges such as antimicrobial resistance, infection control, and the environmental impact of synthetic materials [1][4][8]. Through rigorous independent laboratory testing, their treatments have demonstrated significant efficacy in reducing pathogen populations and sustaining performance even after multiple commercial wash cycles [1][5]. With a focus on sustainable, naturally derived materials, Chitozan Health aims to provide safer, more effective alternatives for infection mitigation across multiple sectors [1][7].
delivered to your inbox.